AWHL — Aspira Womens Health Cashflow Statement
0.000.00%
Last trade - 00:00- $14.50m
- $12.02m
- $9.18m
- 38
- 32
- 68
- 43
Annual cashflow statement for Aspira Womens Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.9 | -31.7 | -29.9 | -16.7 | -13.1 |
| Depreciation | |||||
| Non-Cash Items | 1.58 | 2.57 | 1.35 | 0.372 | 0.192 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.33 | 1.39 | -2.8 | 0.225 | 0.697 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -14.7 | -27.4 | -31.1 | -15.9 | -12.1 |
| Capital Expenditures | -0.49 | -0.184 | -0.232 | -0.024 | -0.037 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.49 | -0.184 | -0.232 | -0.024 | -0.037 |
| Financing Cash Flow Items | 10.6 | -0.377 | -1.32 | -0.134 | -1.27 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.2 | 48.4 | 7.43 | 5.22 | 11.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.93 | 20.8 | -23.9 | -10.7 | -1.09 |